泰科普拉宁的药理动力学和目标达到:系统性审查
Jaap W A Mouton1, Arnaud De Clercq2,3, Peter De Paepe2,3
1Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands.
Clinical pharmacokinetics
|March 11, 2025
概括
本综述综合了不同人群中teicoplanin的药理动力学. 最佳的剂量策略需要个性化的方法,特别是考虑到功能和未结合的药物度.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 临床药房 临床药房
背景情况:
- 泰科普拉宁是一种关键的糖抗生素,用于严重的格兰氏阳性感染.
- 了解其药理动力学 (PK) 对于有效治疗至关重要.
- 现有关于不同人群中泰可普拉宁PK的文献需要全面综合.
研究的目的:
- 系统地审查不同患者群体中的泰可普拉宁的药理动力学.
- 识别当前药理动力学知识的差距.
- 为最佳剂量策略提供信息,并指导未来的研究.
主要方法:
- 在主要数据库 (MEDLINE,Embase,Web of Science,Scopus) 进行系统的文献搜索,直到2024年10月.
- 在八个子组中,对3452名受试者进行了药理动力学参数 (CL,Vd) 的提取和全米缩放.
- 使用临床药理动力学陈述检查清单对研究质量的定性评估.
主要成果:
- 85篇文章提供了不同人群的PK数据,包括新生儿,儿童,成年人,老年人,重症患者和功能障碍患者.
- 观察到尺度清除 (CLscaled) 和分布体积 (Vdscaled) 的显著变化.
- 功能是影响CL的关键共变量,在65.6%的研究中确定了处置关系. 在42.4%的研究中报告了目标实现情况.
结论:
- 个性化泰可普拉宁剂量策略至关重要,特别是在功能障碍患者中.
- 未来的研究应该专注于药理动力学/药理动力学 (PK/PD) 建模和测量未结合的提科普拉宁度.
- 准确评估未结合度对于评估药理动力学和实现目标至关重要.
相关概念视频
Drug Concentration Versus Time Correlation
568
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
568
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
110
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
110
Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K
Nonlinear Pharmacokinetics: Role of Transporters
26
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
26


